Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

BICALUTAMIDE vs BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS: Safety Overview

Metric BICALUTAMIDE BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS
Total FAERS Reports 4,061 176
Deaths Reported 462 0
Death Rate 11.4% N/A
Hospitalizations 1,486 110
Average Patient Age 71.9 yrs 66.0 yrs
% Female Patients 2.1% 91.7%
FDA Approval Date Aug 28, 2009 N/A
Manufacturer Proficient Rx LP N/A
Route ORAL N/A
Marketing Status Prescription N/A